This page provides a comprehensive resource for Calumet (CLMT) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading reports. It details recent filings such as The Heritage Group's amended 13D filing showing changes in beneficial ownership and gifts of shares, as well as multiple Form 4 filings regarding equity awards (Restricted Stock Units) to Calumet directors. The platform also offers AI-generated summaries, impact scoring, and sentiment analysis for each filing.

MetLife offers three exchange-traded preferred stocks (Series A, E, and F) for portfolio diversification, all BBB-rated, non-cumulative, and tax-advantaged. While Series E and F are rated as "Holds" due to their call hierarchy and yield dynamics, Series A has been downgraded to a "Sell" due to its significantly lower yield compared to the others. The author suggests Series A's floating rate offers better price support in rising interest rate environments, yet its current yield underperformance warrants the changed rating.

UniSuper Management Pty Ltd reduced its stake in Danaher Corporation (NYSE:DHR) by 5.6% during the fourth quarter, selling 9,619 shares. Despite this, other institutional investors increased their holdings. Danaher reported strong Q1 earnings, beating analyst estimates, and announced a quarterly dividend of $0.40 per share, contributing to a "Moderate Buy" consensus rating from analysts with an average price target of $233.61.

The J.M. Smucker Company reported strong cat food growth in Q4 fiscal year 2026, driven by Meow Mix, which helped offset a decline in dog snacks, particularly Milk-Bone. While dog snack sales faced softness, the company plans strategic initiatives, including product innovation and e-commerce expansion, to reaccelerate growth across both pet food segments. Overall, the company delivered positive net sales and earnings growth and provided guidance for fiscal year 2027.

AbbVie announced long-term follow-up results from its Phase 3 CLL14 clinical trial at EHA 2026, demonstrating the durable efficacy of Venclexta (venetoclax) as a fixed-duration therapy for previously untreated chronic lymphocytic leukemia (CLL) patients. The nine-year data showed a median progression-free survival of 6.4 years and a median time to next treatment of 7.6 years for patients treated with Venclexta plus obinutuzumab, affirming its role in frontline CLL care. The safety profile remained consistent, highlighting predictable disease control without continuous long-term dosing.

SpaceX's record-setting $75 billion IPO has led to an explosion in leveraged ETFs designed to amplify its daily returns, such as the ProShares Ultra SpaceX ETF (SPCF). While these funds promise magnified gains, they reset daily, making them unsuitable for long-term investors due to daily compounding and volatility drag, which can lead to losses even if SpaceX stock moves as predicted over longer periods. Investors are warned to stick to SpaceX stock itself or index funds for exposure, as leveraged ETFs are built for short-term traders, not wealth accumulation.

Braemar Hotels & Resorts (NYSE: BHR) announced a strategic plan to become a self-managed REIT, concluding a lengthy review process. This move involves terminating its advisory agreement with Ashford, reconstituting its Board with new independent directors, and directly hiring its management team, which is expected to save over $25 million annually in G&A costs. The company aims to simplify its corporate structure, improve governance, and enhance shareholder value, while maintaining a portfolio of 6-8 luxury properties.

Weitz Investment Management Inc. increased its stake in Roper Technologies (NASDAQ:ROP) by 16.3% in the fourth quarter, bringing its total holdings to 36,550 shares valued at $16.27 million. Other institutional investors like Vanguard Group Inc. also significantly boosted their positions. Roper Technologies reported strong quarterly results with EPS of $5.16 and revenue up 11.3%, and declared a quarterly dividend of $0.91 per share.

Baidu's Apollo Go, through its partnership with PostBus under the "AmiGo" service, has received a Level 4 regulatory permit in Switzerland. This approval allows for autonomous driving trials in an 80 km² area across three cantons in Eastern Switzerland, with fully driverless public transport operations anticipated by early 2027. This initiative is set to become Europe's largest planned automated public transport operation of its kind.

Braemar Hotels & Resorts Inc. announced its decision to terminate its advisory agreement with Ashford Inc. and affiliates, transitioning to a self-managed REIT to establish an in-house management team. This strategic move aims to reduce general and administrative costs by over $25 million annually and will involve a near-total reconstitution of its board of directors. The company, which maintains a portfolio of luxury properties, will use net proceeds from asset sales to pay termination fees to Ashford.